We used human glioblastoma patient–derived primary neurosphere cells, named “1123”, which has been shown to possess stem cell-like characteristics including a high level of CD44 expression, self-renewal capability and tumorigenicity when implanted in mouse brain [24-26]. The gene discussed is CD44; the disease is glioblastoma.